<DOC>
	<DOCNO>NCT02994446</DOCNO>
	<brief_summary>The purpose study demonstrate technical feasibility SERF Catheter SERF Cardiac Ablation System eliminate control ventricular tachycardia ( VT )</brief_summary>
	<brief_title>Saline-Enhanced Radiofrequency ( SERF ) Catheter Ablation Treatment Ventricular Tachycardia</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Ischemic post myocardial infarction ventricular tachycardia ( VT ) Scar identify image Drug refractory drug intolerant VT follow use least one Class III antiarrhythmic demonstrate recurrent arrhythmia suitable candidate per investigator 's expert opinion ongoing alternative drug therapy Prior fail ablation evidence implantable cardioverter defibrillator device therapy within prior 3 month Minimum 3 month implantable cardioverter defibrillator interrogation history available Left ventricular ejection fraction great equal 20 % 1875 year old Signed informed consent willing able participate study procedure follow requirement Patients without ischemic , scarrelated VT VT finding suggestive right ventricular free wall origin finding VT septal origin may exclude . Patients require ablation location include arrhythmia lifethreatening otherwise sufficiently severe justify risk . Myocardial infarction unstable angina within previous 60 day Cardiac surgery percutaneous coronary intervention within previous 60 day Patients NYHA class IV heart failure Prosthetic cardiac valve ( ) , severe aortic stenosis flail mitral valve Left ventricular assist device plan required procedure Comorbidities patient le 1 year life expectancy Significant intracardiac and/or laminate thrombus prior ablation procedure Thrombocytopenia coagulopathy Pregnancy Other acute illness active systemic infection ( unrelated VT origin ) Significant congenital anomaly heart disease Allergy contraindication medications/agents use standard ablation/EP intervention . Concurrently enrol investigational drug device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>